" /> Corticosterone methyloxidase type II deficiency - CISMeF





Preferred Label : Corticosterone methyloxidase type II deficiency;

CISMeF acronym : FHHA1B;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Aldosterone deficiency II; FHHA1B; Steroid 18-oxidase deficiency; Aldosterone deficiency due to deficiency of steroid 18-oxidase; 18-oxidase deficiency; Cmo II deficiency; Hyperreninemic hypoaldosteronism, familial, 1;

Description : CMO type II deficiency is an autosomal recessive disorder caused by a defect in the final biochemical step of aldosterone biosynthesis, the 18-hydroxylation of 18-hydroxycorticosterone (18-OHB) to aldosterone. This enzymatic defect results in decreased aldosterone and salt-wasting associated with an increased serum ratio of 18-OHB to aldosterone. In CMO II deficiency, aldosterone can be low or normal, but at the expense of increased secretion of 18-OHB. These patients have a low ratio of corticosterone to 18-OHB (Portrat-Doyen et al., 1998). The CYP11B2 gene product also catalyzes an earlier step in aldosterone biosynthesis: the 18-hydroxylation of corticosterone to 18-OHB. A defect in that enzymatic step results in CMO type I deficiency (204300), an allelic disorder with an overlapping phenotype but distinct biochemical features. In CMO I deficiency, aldosterone is undetectable, whereas its immediate precursor, 18-OHB, is low or normal (Portrat-Doyen et al., 1998).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the cytochrome P450, subfamily XIB, polypeptide 2 gene (CYP11B2, 124080.0001);

Laboratory abnormalities : Decreased serum aldosterone; Increased serum 18-hydroxycorticosterone (18-OHB); Increased 18-OHB to aldosterone ratio; Increased serum renin; Hyponatremia; Hyperkalemia;

Prefixed ID : #610600;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.